http://www.startribune.com/in-surprise-celebrex-found-to-be-no-riskier-for-hearts-than-ibuprofen/401170485/
http://patentlyo.com/patent/2016/11/supreme-patent-exhaustion.html
http://realnewsmagazine.net/business/merck-marks-world-diabetes-day-diabetes-award-2016-winners/
http://military-technologies.net/2016/11/14/opgen-collaborates-with-merck-to-develop-novel-rapid-diagnostics-and-informatics-tools-to-combat-antibiotic-resistance/
https://www.thenigerianvoice.com/news/236752/merck-marks-world-diabetes-day-wdd-with-the-announcement-o.html
http://www.africa-newsroom.com/press/merck-marks-world-diabetes-day-wdd-with-the-announcement-of-their-diabetes-award-2016-winners-merckwdd2016
http://www.post-gazette.com/news/nation/2016/11/14/Celebrex-is-found-to-be-no-riskier-for-hearts-than-other-pain-drugs/stories/201611140091
http://www.4-traders.com//MERCK-CO-INC-13611/news/Merck-Announces-Findings-for-Investigational-Triple-Combination-Chronic-Hepatitis-C-Therapy-Showin-23391388/

http://www.prnewswire.co.uk/news-releases/merck-remporte-un-prix-rd-100-pour-son-innovation-600837471.html
http://military-technologies.net/2016/11/14/htg-molecular-diagnostics-reports-third-quarter-2016-results/
http://www.pmlive.com/pharma_news/chmp_recommends_merck_and_cos_lantus_biosimilar_1176581
https://www.washingtonpost.com/news/to-your-health/wp/2016/11/13/surprising-new-findings-about-pain-relievers-taken-by-everyone-on-the-planet/
http://www.benzinga.com/general/biotech/16/11/8696936/gilead-responds-to-cms-blog-highlighting-high-cost-of-harvoni-most-pay
http://politi.co/2fSp5eg
http://www.euronews.com/2016/11/10/business-winners-and-losers-from-the-trump-presidency?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%253A%2Beuronews%252Fen%252Fbusiness%2B%2528euronews%2B-%2Bbusiness%2B-%2Ben%2529&utm_content=FeedBurner
http://www.ssuchronicle.com/2016/11/14/staywell-unveils-krames-health-engagement-platform/
http://www.latinpost.com/articles/126276/20161114/celebrex-found-harmless-hearts-study-suggests.htm
http://www.techtimes.com/articles/185687/20161113/arthritis-drug-celebrex-is-safe-for-heart-health-study.htm
http://www.startribune.com/readers-write-nov-14-vaping-prescription-drugs-senior-housing-teach-for-america-the-trump-presidency/400893871/
http://www.theguardian.com/global-development/2016/nov/14/gsk-tops-list-of-drug-firms-improving-global-access-to-medicine
http://www.dailymail.co.uk/~/article-3932674/index.html
http://www.telegraph.co.uk/business/2016/11/13/donald-trumps-election-to-trigger-new-era-of-pharma-mega-mergers/
http://www.emailwire.com/release/297678-Antihypertensive-Drug-Market-Research-Size-Share-Analysis-By-Manufacturers-Regions-Type-And-Application-To-2021-in-United-State.html
http://www.emailwire.com/release/297681-Diuretics-Market-Research-Size-Share-Analysis-By-Manufacturers-Regions-Type-And-Application-To-2021-in-United-State.html
http://lifestyle.inquirer.net/243764/hillary-clinton-the-true-winner/
http://www.medpagetoday.com/Cardiology/Arrhythmias/61420
http://www.cbc.ca/radio/whitecoat/noisy-hospitals-are-putting-patients-at-risk-here-s-why-1.3847486/how-a-trump-presidency-could-affect-health-care-in-canada-1.3850064
http://www.medicalnewstoday.com/releases/314097.php
https://www.wealthdaily.com/articles/buy-buy-buy/8419?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%253A%2Bwealthdaily%2B%2528Wealth%2BDaily%2529
http://voiceregistrar.com/2016/11/14/biotech-stocks-worth-a-closer-look-anthera-pharmaceuticals-inc-nasdaqanth-dynavax-technologies-corporation-nasdaqdvax/
http://www.irishtimes.com/news/science/big-data-scientist-wins-researcher-of-the-year-award-1.2867845

http://abcnews.go.com/Business/wireStory/us-stocks-move-higher-banks-surge-bond-yields-43523423
https://www.abqjournal.com/888471/us-stocks-move-higher-as-banks-surge-with-bond-yields.html
http://www.stltoday.com/business/national-and-international/us-stocks-move-higher-as-banks-surge-with-bond-yields/article_46c0805e-fc57-5fca-92d7-9ae05a7e5c8d.html
http://www.emailwire.com/release/297861-Pharmaceutical-Contract-Manufacturing-Market-2016-Geographical-Segmentation-Size-Trends-Growth-and-Forecasts.html
http://www.emailwire.com/release/297870-Autoimmune-and-Inflammatory-Immunomodulators-Market-2016-Geographical-Segmentation-Size-Trends-Growth-and-Forecasts.html
http://www.prnewswire.com/news-releases/two-studies-reveal-differences-in-real-world-treatment-patterns-in-rheumatoid-arthritis-patients-taking-remicade-infliximab-compared-to-ct-p13-infliximab-biosimilar-300361803.html

http://medcitynews.com/2014/12/immunotherapy-sti-treatment-agenus-ceo-genital-herpes-vaccine/
http://satprnews.com/2016/11/13/alnylam-pharmaceuticals-and-the-medicines-company-announce-publication-of-phase-1-clinical-data-with-inclisiran-aln-pcssc-in-the-new-england-journal-of-medicine/

http://military-technologies.net/2016/11/13/alnylam-pharmaceuticals-and-the-medicines-company-announce-publication-of-phase-1-clinical-data-with-inclisiran-aln-pcssc-in-the-new-england-journal-of-medicine/
http://www.nytimes.com/aponline/2016/11/14/world/asia/ap-financial-markets.html
http://www.sltrib.com/home/4583331-155/us-stocks-move-higher-as-banks
http://timesofkabul.com/4669/cis-insulin-market-global-industry-perspective-comprehensive-analysis-forecast-2014-2020-explored-latest-research/
http://www.eurekalert.org/pub_releases/2016-11/mgh-sff111016.php
http://www.medpagetoday.com/mastery-of-medicine/rheumatology-mastery-in-as/61383
http://military-technologies.net/2016/11/13/xencor-presents-preliminary-data-from-an-ongoing-open-label-phase-2-study-of-xmab5871-in-igg4-related-disease-igg4-rd-at-the-american-college-of-rheumatology-2016-annual-meeting/
http://satprnews.com/2016/11/13/xencor-presents-preliminary-data-from-an-ongoing-open-label-phase-2-study-of-xmab5871-in-igg4-related-disease-igg4-rd-at-the-american-college-of-rheumatology-2016-annual-meeting/
http://www.koreaherald.com/view.php?ud=20161113000213
